A UI Civil Engineering graduate shared how his CGPA improved from 2.81 to 3.25 before graduation and celebrated his induction into the Nigerian Society of Engineers.

Based on the Strength of Unprecedented Results from the Positive Phase 1/2 Study in Adults Aged 50 and Older, Vaxcyte ...

Nektar Therapeutics (Nasdaq: NKTR) announced today that data from the ongoing Phase 2b studies of rezpegaldesleukin in atopic ...

With the regular season gearing up, Los Angeles Dodgers fans should be wary about overindulging on gameday snacks, according to one study.

TACTI-004 planned ~756 patients across >150 sites and enrolled 378 by February 2026, including squamous and nonsquamous NSCLC irrespective of PD-L1 status. Randomization compared eftilagimod alfa plus ...

Spyre Therapeutics, Inc. earns a Strong Buy on Phase 1 wins, IBD/RA pipeline catalysts, and $757M cash runway. Click for this ...

A young man has celebrated completing his computer science studies at OAUSTECH. He shared his academic journey and his CGPA ...

Analysts remain intrigued by aleniglipron’s potential in the oral GLP-1RA market, though they note it is too early to compare the drug’s efficacy to Eli Lilly’s orforglipron.

Late-breaking AMETHYST Part A study results to be presented, showing safety and efficacy of litifilimab in cutaneous lupus erythematosus (CLE)Litifilimab was recently granted Breakthrough Therapy ...

GIP obesity drug enters Phase 3 with strong cash runway, but rising competition and trial risk. Click for this VKTX update.

According to a team of researchers at Baylor College of Medicine, Tongji University and collaborating institutions, weaning ...

The findings suggest that use of the pacing technique during CRT should be reserved for expert operators, at least for now.